Q4 2020 13F Holders as of 31 Dec 2020
-
Type / Class
-
Equity / COM
-
Number of holders
-
250
-
Total 13F shares, excl. options
-
62,181,163
-
Shares change
-
-1,131,296
-
Total reported value, excl. options
-
$2,690,654,040
-
Value change
-
-$65,671,775
-
Put/Call ratio
-
105%
-
Number of buys
-
128
-
Number of sells
-
140
-
Price
-
$43.27
Institutional Holders of BLUEBIRD BIO INC - COM (BLUE) as of Q4 2020
As of 31 Dec 2020 BLUEBIRD BIO INC - COM (BLUE) had 356 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 62,181,163 shares of stock of the company.
Largest 10 holders included Capital Research Global Investors, VANGUARD GROUP INC, WELLINGTON MANAGEMENT GROUP LLP, BlackRock Inc., ROYAL BANK OF CANADA, SANDS CAPITAL MANAGEMENT, LLC, Capital World Investors, STATE STREET CORP, CREDIT SUISSE AG/, and VICTORY CAPITAL MANAGEMENT INC.
This table shows 356 institutional shareholders of the security as of 31 Dec 2020.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.